Akoya Biosciences, Inc. (AKYA)
USD 1.03
(-11.97%)
USD 1.03
(-11.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.58 Million USD | 65.98% |
| 2022 | 1.55 Million USD | 101.93% |
| 2021 | -80.6 Million USD | -548.12% |
| 2020 | 17.98 Million USD | 37.16% |
| 2019 | 13.11 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 72.14 Million USD | 2695.39% |
| 2024 Q2 | 75.77 Million USD | 5.03% |
| 2023 Q1 | 15.02 Million USD | 866.43% |
| 2023 FY | 2.58 Million USD | 65.98% |
| 2023 Q3 | -3.52 Million USD | 80.05% |
| 2023 Q2 | -17.65 Million USD | -217.49% |
| 2023 Q4 | 2.58 Million USD | 173.28% |
| 2022 Q2 | 9.06 Million USD | 118.05% |
| 2022 Q1 | -50.22 Million USD | 37.7% |
| 2022 Q4 | 1.55 Million USD | -88.8% |
| 2022 FY | 1.55 Million USD | 101.93% |
| 2022 Q3 | 13.89 Million USD | 53.24% |
| 2021 Q4 | -80.6 Million USD | 7.61% |
| 2021 Q2 | -102.59 Million USD | -534.51% |
| 2021 Q1 | 23.61 Million USD | 31.26% |
| 2021 FY | -80.6 Million USD | -548.12% |
| 2021 Q3 | -87.24 Million USD | 14.96% |
| 2020 Q4 | 17.98 Million USD | 0.0% |
| 2020 FY | 17.98 Million USD | 37.16% |
| 2020 Q1 | 21.65 Million USD | 0.0% |
| 2019 FY | 13.11 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AngioDynamics, Inc. | -70.14 Million USD | 103.68% |
| AtriCure, Inc. | -9.81 Million USD | 126.294% |
| Avinger, Inc. | 10.12 Million USD | 74.496% |
| Azenta, Inc. | -618.47 Million USD | 100.417% |
| BioLife Solutions, Inc. | 7.25 Million USD | 64.415% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.895% |
| Daxor Corporation | 755.65 Thousand USD | -241.556% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 275.578% |
| Femasys Inc. | -15.01 Million USD | 117.189% |
| GlucoTrack, Inc. | -4.29 Million USD | 160.079% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 93.294% |
| Hologic, Inc. | 374.4 Million USD | 99.311% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.822% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.097% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 136.677% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 149.884% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 160.199% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 160.199% |
| Masimo Corporation | 804 Million USD | 99.679% |
| Microbot Medical Inc. | -2.28 Million USD | 212.905% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 126.897% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 99.146% |
| Nephros, Inc. | -2.47 Million USD | 204.452% |
| NovoCure Limited | 355.42 Million USD | 99.274% |
| NEXGEL, Inc. | 98 Thousand USD | -2533.673% |
| NEXGEL, Inc. | 98 Thousand USD | -2533.673% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 95.629% |
| OraSure Technologies, Inc. | -276.9 Million USD | 100.932% |
| Pro-Dex, Inc. | 10.91 Million USD | 76.356% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 107.328% |
| Predictive Oncology Inc. | -5.87 Million USD | 143.956% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 14.796% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.897% |
| Repligen Corporation | -39.51 Million USD | 106.531% |
| Sanara MedTech Inc. | 6.64 Million USD | 61.158% |
| STAAR Surgical Company | -147.2 Million USD | 101.753% |
| Sharps Technology, Inc. | -3.01 Million USD | 185.665% |
| Utah Medical Products, Inc. | -92.52 Million USD | 102.789% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.869% |
| Jin Medical International Ltd. | -2.81 Million USD | 191.638% |